← All Medicure INC filings

Medicure INC 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

OTC.Pink
MCUJF
Medicure INC
20-F: Medicure Inc. Files 20-F Annual Report for Fiscal Year 2024
Medicure Inc. releases its 20-F filing, detailing financial performance and strategic initiatives for the year ended December 31, 2024.
OTC.Pink
MCUJF
Medicure INC
20-F: Medicure Inc. Reports Full Year 2023 Results: AGGRASTAT Sales Decline Amidst Generic Competition, Marley Drug Revenue Increases
Medicure Inc.'s 2023 results reveal a decrease in AGGRASTAT sales due to generic competition, offset by growth in Marley Drug's revenue.